Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,813 | 15,866 | 16,097 | 29,785 | 33,509 |
| Marketable Securities | 14,858 | 9,226 | 9,003 | 7,567 | N/A |
| Receivables | 24,780 | 20,774 | 19,909 | 16,745 | 16,450 |
| Inventories | 6,337 | 6,379 | 5,635 | 4,939 | 4,281 |
| Other current assets | 5,809 | 1,513 | 1,722 | 1,897 | 1,434 |
| TOTAL | $64,786 | $54,809 | $53,519 | $62,723 | $57,221 |
| Non-Current Assets | |||||
| PPE Net | 23,880 | 24,442 | 23,672 | 23,564 | 23,288 |
| Investments And Advances | 24,568 | 29,515 | 28,799 | 23,106 | 23,431 |
| Intangibles | 1,705 | 1,663 | 1,650 | 1,676 | 1,698 |
| Other Non-Current Assets | 10,467 | 14,811 | 13,289 | 10,941 | 10,901 |
| TOTAL | $60,620 | $70,431 | $67,410 | $59,287 | $59,318 |
| Total Assets | $125,406 | $125,240 | $120,929 | $122,010 | $116,539 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 335 | 1,591 | 2,083 | 2,114 | 2,809 |
| Accrued Expenses | 10,615 | 9,553 | 10,513 | 10,767 | 11,935 |
| Other current liabilities | 5,022 | N/A | N/A | N/A | 39 |
| TOTAL | $19,516 | $14,716 | $15,574 | $19,486 | $20,047 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 36 | 57 | 35 | N/A |
| Other Non-Current Liabilities | 6,820 | 10,318 | 10,999 | 11,350 | 17,989 |
| TOTAL | $7,488 | $12,050 | $12,009 | $13,753 | $18,018 |
| Total Liabilities | $27,004 | $26,766 | $27,583 | $33,239 | $38,065 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,612 | 93,521 | 93,424 | 85,510 | 85,423 |
| Common Shares | 86 | 85 | 85 | 85 | 77 |
| Retained earnings | -73,453 | -73,354 | -74,478 | -78,006 | -85,538 |
| Other shareholders' equity | 35,584 | 37,447 | 34,083 | 33,493 | 95,756 |
| TOTAL | $98,402 | $98,474 | $93,346 | $88,771 | $78,474 |
| Total Liabilities And Equity | $125,406 | $125,240 | $120,929 | $122,010 | $116,539 |